title: Ligand-binding domain subregions contributing to bimodal agonism in cyclic nucleotide-gated channels.
abstract: Cyclic nucleotide-gated (CNG) channels bind cGMP or cAMP in a cytoplasmic ligand-binding domain (BD), and this binding typically increases channel open probability (P(o)) without inducing desensitization. However, the catfish CNGA2 (fCNGA2) subtype exhibits bimodal agonism, whereby steady-state P(o) increases with initial cGMP-binding events ("pro" action) up to a maximum of 0.4, but decreases with subsequent cGMP-binding events ("con" action) occurring at concentrations >3 mM. We sought to clarify if low pro-action efficacy was either necessary or sufficient for con action to operate. To find BD residues responsible for con action or low pro-action efficacy or both, we constructed chimeric CNG channels: subregions of the fCNGA2 BD were substituted with corresponding sequence from the rat CNGA4 BD, which does not support con action. Constructs were expressed in frog oocytes and tested by patch clamp of cell-free membranes. For nearly all BD elements, we found at least one construct where replacing that element preserved robust con action, with a ratio of steady-state conductances, g((10 mM cGMP))/g((3 mM cGMP)) < 0.75. When all of the BD sequence C terminal of strand β6 was replaced, g((10 mM cGMP))/g((3 mM cGMP)) was increased to 0.95 ± 0.05 (n = 7). However, this apparent attenuation of con action could be explained by an increase in the efficacy of pro action for all agonists, controlled by a conserved "phosphate-binding cassette" motif that contacts ligand; this produces high P(o) values that are less sensitive to shifts in gating equilibrium. In contrast, substituting a single valine in the N-terminal helix αA abolished con action (g((30 mM cGMP))/g((3 mM cGMP)) increased to 1.26 ± 0.24; n = 7) without large increases in pro-action efficacy. Our work dissociates the two functional features of low pro-action efficacy and con action, and moreover identifies a separate structural determinant for each.
authors.affiliation: Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.
authors.forename: Wai-Fung
authors.initials: WF
authors.lastname: Wong
authors.forename: Kerry S C
authors.initials: KS
authors.lastname: Chan
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Michaleski
authors.forename: Adam
authors.initials: A
authors.lastname: Haesler
authors.forename: Edgar C
authors.initials: EC
authors.lastname: Young
mesh_terms: D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000818:Animals; D054815:Cyclic Nucleotide-Gated Cation Channels / Q000819:agonists* / Q000737:chemistry / Q000378:metabolism*; D004274:DNA, Recombinant; D004594:Electrophysiology; D008024:Ligands; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009865:Oocytes; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D051381:Rats; D014981:Xenopus
chemical_list: D054815:Cyclic Nucleotide-Gated Cation Channels; D004274:DNA, Recombinant; D008024:Ligands